.........“We met with RBI officials few days ago and they were apprehensive about our preparedness to meet Basel III norms. They were relieved to know that we would not require any capital infusion till the year 2019,” AK Jagannathan, managing director of TMB told................
The very purpose of VITALINFO is to provide a platform for wider dissemination of updated information related to and happening of events in and around RBI.
No comments:
Post a Comment